VERAInvestor Conferences•globenewswire•August 26, 2025 at 08:05 PM

Vera Therapeutics to Participate at Upcoming Investor Conferences

Sentiment:Negative (30)

Summary

BRISBANE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company’s management team will present and participate in one-on-one meetings at upcoming investor conferences.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 26, 2025 by globenewswire